Page last updated: 2024-11-01

nisoldipine and Body Weight

nisoldipine has been researched along with Body Weight in 6 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"We have assessed the efficacy and tolerance of Nifedipine twice daily and Nisoldipine once daily, both alone and in combination with a beta-blocker in 171 essential hypertensives in a randomized parallel comparison fashion."6.66The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study. ( Rosenfeld, JB; Zabludowski, J, 1989)
"This study examined the protective effects of a calcium channel blocker, nisoldipine (NSL), against organ damage secondary to severe hypertension."3.69Benefits and demerits of antihypertensive therapy by high-dose calcium channel blocker in severely hypertensive rats. ( Ishimitsu, T; Ogawa, Y; Tsukada, H; Yagi, S, 1994)
"We have assessed the efficacy and tolerance of Nifedipine twice daily and Nisoldipine once daily, both alone and in combination with a beta-blocker in 171 essential hypertensives in a randomized parallel comparison fashion."2.66The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study. ( Rosenfeld, JB; Zabludowski, J, 1989)
" This study was undertaken in adult male New Zealand rabbits to assess the effect of 3 weeks of dosing with NIS (1 mg."1.30A high cholesterol diet blocks the effect of calcium channel blockers on the uptake of sugars in rabbit intestine. ( Hyson, DH; Kappagoda, CT; Keelan, M; Thomson, AB, 1997)
"Treatment with nisoldipine prevented the detrimental impact of ischemic heart disease to an extent that all measured parameters in CANN rats were found to be intermediate between unoperated controls and CANW animals."1.29Nisoldipine improves ventricular function in rats with ischemic heart failure. ( Capasso, JM, 1995)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogawa, Y1
Ishimitsu, T1
Tsukada, H1
Yagi, S1
Capasso, JM1
Hyson, DH1
Thomson, AB1
Keelan, M1
Kappagoda, CT1
Ruilope, LM1
Miranda, B1
Garcia-Robles, R1
Bigorra, J1
Oliet, A1
Alcazar, JM1
Sancho Rof, J1
Rodicio, JL1
Fields, N1
Tsoporis, J1
Leenen, FH1
Rosenfeld, JB1
Zabludowski, J1

Trials

1 trial available for nisoldipine and Body Weight

ArticleYear
The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study.
    Journal of clinical pharmacology, 1989, Volume: 29, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Body Weight; Double-Blind Method; Drug The

1989

Other Studies

5 other studies available for nisoldipine and Body Weight

ArticleYear
Benefits and demerits of antihypertensive therapy by high-dose calcium channel blocker in severely hypertensive rats.
    Japanese heart journal, 1994, Volume: 35, Issue:3

    Topics: Animals; Antihypertensive Agents; Aorta; Body Weight; Calcium Channel Blockers; Cardiomegaly; Dose-R

1994
Nisoldipine improves ventricular function in rats with ischemic heart failure.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:9

    Topics: Animals; Body Weight; Calcium; Calcium Channel Blockers; Coronary Vessels; Hemodynamics; Male; Myoca

1995
A high cholesterol diet blocks the effect of calcium channel blockers on the uptake of sugars in rabbit intestine.
    Canadian journal of physiology and pharmacology, 1997, Volume: 75, Issue:1

    Topics: Animals; Biological Transport; Body Weight; Calcium Channel Blockers; Carbohydrates; Cholesterol, Di

1997
Effects of nisoldipine on renal function in normal volunteers and essential hypertensive patients.
    Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:1

    Topics: Adult; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Hyp

1989
Differential effects of the calcium antagonist, nisoldipine, versus the arterial vasodilator, minoxidil, on ventricular anatomy, intravascular volume, and sympathetic activity in rats.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:6

    Topics: Animals; Blood Volume; Body Weight; Catecholamines; Drinking; Eating; Heart; In Vitro Techniques; Ma

1989